NADA Number: 048-010

Proprietary Name Anaplex Caps
Canine and Feline Wormer Caps
Sponsor Boehringer Ingelheim Vetmedica, Inc.
Sponsor Address 2621 North Belt Highway
St.Joseph, MO    64502
USA
Ingredients Toluene
Dichlorophene
Species Cat, no use class stated or implied
Dog, no use class stated or implied
Routes of Administration Per Os
Dose Form Capsule
Drug Form Capsule
Dispensing Status OTC
Dosage Amount,
Indications
& Limitations

520.580 Dichlorophene and toluene capsules.

Specifications: Each soft gelatin capsule contains 50 milligrams of dichlorophene and 60 milligrams of toluene or multiples thereof.

Conditions of use:

Dogs

Amount: Single dose of 100 milligrams of dicholorophene and 120 milligrams of toluene per pound of body weight.

Indications: It is used for the removal of ascarids (Toxocara canis and Toxascaris leonina) and hookworms (Ancylostoma caninum and Uncinaria stenocephala) and as an aid in removing tapeworms (Taenia pisiformis, Dipylidium caninum, and Echinococcus granulosus) from dogs.

Limitations: Withhold solid foods and milk for at least 12 hours prior to medication and for 4 hours afterward. Repeat treatment in 2 to 4 weeks in animals subject to reinfection. Must include the required statement: Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism, and before administering to weak or debilitated animals.

Cats

Amount: Single dose of 100 milligrams of dicholorophene and 120 milligrams of toluene per pound of body weight.

Indications: It is used for the removal of ascarids (Toxocara canis and Toxascaris leonina) and hookworms (Ancylostoma caninum and Uncinaria stenocephala) and as an aid in removing tapeworms (Taenia pisiformis, Dipylidium caninum, and Echinococcus granulosus) from cats.

Limitations: Withhold solid foods and milk for at least 12 hours prior to medication and for 4 hours afterward. Repeat treatment in 2 to 4 weeks in animals subject to reinfection. Must include the required statement: Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism, and before administering to weak or debilitated animals.

NAS/NRC status: These conditions are NAS/NRC reviewed and deemed effective. Applications for these uses need not include effectiveness data as specified by 514.111 of this chapter, but may require bioequivalency and safety information.